https://blog.lifesciencenation.com/2026/11/10/hot-investor-mandate-vc-invests-in-emerging-therapeutics-medical-device-and-digital-health-companies-investing-in-earliest-stages-of-development/Next Phase Newsletteren2026-11-10T18:08:25+00:00Hot Investor Mandate: VC Invests in Emerging Therapeutics, Medical Device, and Digital Health Companies, Investing in Earliest Stages of Developmenttechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/11/10/hot-investor-mandate-usa-based-healthcare-vc-invests-in-pre-seed-and-seed-stage-digital-therapeutics-diagnostics-and-medical-devices/Next Phase Newsletteren2026-11-10T18:08:08+00:00Hot Investor Mandate: USA-Based Healthcare VC Invests in Pre-Seed and Seed Stage Digital Therapeutics, Diagnostics, and Medical Devicestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/11/10/hot-investor-mandate-strategic-investment-arm-of-pharmaceutical-company-targets-early-stage-oncology-immunology-and-metabolic-therapeutics/Next Phase Newsletteren2026-11-10T18:07:44+00:00Hot Investor Mandate: Strategic Investment Arm of Pharmaceutical Company Targets Early-Stage Oncology, Immunology, and Metabolic Therapeuticstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/11/10/hot-investor-mandate-global-pharma-cvc-invests-in-seed-and-series-a-therapeutics-drug-discovery-and-enabling-technologies/Next Phase Newsletteren2026-11-10T18:07:23+00:00Hot Investor Mandate: Global Pharma CVC Invests in Seed and Series A Therapeutics, Drug Discovery, and Enabling Technologiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence